Vitality Watch

Dossier pubmed review 13-apr-2026
Narrative review or expert overview without new data

The metabolic-inflammatory axis in aging: A multi-organ framework anchored in Sarcopenia - A review.

Key claim: Sarcopenia anchors a multi-organ metabolic-inflammatory axis in which gut–liver–adipose–muscle crosstalk, insulin resistance, and shared AMPK/mTOR, mtROS–p53, and AcCoA–HAT modules drive age-related multi-system dysfunction.

Abstract

Inflammaging refers to chronic low‑grade inflammation that develops with age and promotes multiple age‑related diseases. It arises from the close crosstalk between metabolic disturbance and inflammation, yet how this coupling acts across tissues remains poorly understood. As a hallmark of aging, sarcopenia often coincides with metabolic‑inflammatory dysfunction in the gut, liver, and adipose tissue, all tied together by insulin resistance (IR). In this review, we systematically examine the pathophysiological basis of the “metabolic-inflammatory axis” during aging, clarifying its conceptual boundaries with related terms such as “inflammaging,” “immunometabolism,” and “metabolic inflammation.” We delineate the roles of three core molecular modules-nutrient sensing pathways (AMP‑activated protein kinase (AMPK)/mechanistic target of rapamycin (mTOR)), mitochondrial stress (mitochondrial reactive oxygen species (mtROS)-p53), and epigenetic regulation (acetyl‑Coenzyme A (AcCoA)-histone acetyltransferase (HAT))-in mediating metabolic-inflammatory coupling. Using sarcopenia as a clinical anchor, we construct a tissue-specific atlas of the metabolic-inflammatory axis and elucidate the principles of organ crosstalk-and its mediators-within the gut-liver-adipose-muscle (GLAM) core axis. We then summarize current intervention strategies stratified by evidence level and identify knowledge gaps and future research directions. This review establishes a mechanistic link between molecular pathways and age-related multi-organ dysfunction, supporting a paradigm shift from single-disease management to multi-system healthspan interventions in aging.

Why this matters

This review consolidates several previously siloed mechanism pages (nutrient sensing, mitochondrial dysfunction, inflammaging, epigenetic drift, gut–liver signaling) into a sarcopenia-anchored multi-organ framework, offering a testable map of how muscle decline could act as both output and amplifier of systemic aging. Its value is organizational rather than evidentiary — it is a synthesis of known modules, not a new causal claim — and each invoked module still sits at its own preclinical or mechanism-plausible tier. Watch for downstream work that uses GLAM as a scaffold to generate coordinated multi-organ biomarker panels or combination interventions, which would be the first sign the framework is doing more than relabeling existing biology.

Source

Link

Briefing card

The metabolic-inflammatory axis in aging: A multi-organ framework anchored in Sarcopenia - A review.
Stage: review · pubmed · 13-apr-2026

Sarcopenia anchors a multi-organ metabolic-inflammatory axis in which gut–liver–adipose–muscle crosstalk, insulin resistance, and shared AMPK/mTOR, mtROS–p53, and AcCoA–HAT modules drive age-related multi-system dysfunction.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1016/j.archger.2026.106254

build build 880 · 2bcef25 · 2026-11-18